chr14-65076553-C-T
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PM1BP4_StrongBP6BS1BS2
The NM_002382.5(MAX):c.406G>A(p.Gly136Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000384 in 1,614,098 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002382.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152092Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000994 AC: 25AN: 251488Hom.: 0 AF XY: 0.0000809 AC XY: 11AN XY: 135920
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1461888Hom.: 0 Cov.: 34 AF XY: 0.0000234 AC XY: 17AN XY: 727244
GnomAD4 genome AF: 0.000184 AC: 28AN: 152210Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74406
ClinVar
Submissions by phenotype
not provided Uncertain:1
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Identified in individual(s) with personal or family history of breast and/or ovarian cancer (PMID: 36315513); This variant is associated with the following publications: (PMID: 36315513) -
Pheochromocytoma Benign:1
The MAX c.406G>A (p.Gly136Arg) missense change has a maximum subpopulation frequency of 0.096% in gnomAD v2.1.1 (BS1; https://gnomad.broadinstitute.org/variant/14-65543271-C-T). This is higher than expected for a pathogenic variant predisposing to hereditary paraganglioma-pheochromocytoma syndrome (PMID: 20301715). In silico tools are not in agreement about the effect of this variant on protein function, but to our knowledge these predictions have not been confirmed by functional assays. To our knowledge, this variant has not been reported in individuals with paraganglioma or pheochromocytoma. In summary, this variant meets criteria to be classified as likely benign based on the ACMG/AMP criteria: BS1. -
Hereditary cancer-predisposing syndrome Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Hereditary pheochromocytoma-paraganglioma Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at